Improving Symptoms of Primary Sclerosing Cholangitis by Iranian Traditional Medicine
author
Abstract:
Introduction: Primary Sclerosing Cholangitis (PSC) is a chronic cholestatic disease that results from the inflammation and destruction of intra- and extra-hepatic bile ducts and fibrosis which can lead to cirrhosis. The purpose of this report is to provide the clinical experience of Iranian traditional medicine with the best therapeutic effect within the shortest time. Case Presentation: A 47-year-old man with a known case of IBD for 20 years and PSC for 6 years with severe pruritus, scored 7 based on a Visual Analogue Scale (VAS) and fatigue, but scored 8 based on VAS. The patient had depression due to the long duration of the disease, no certain treatments, and intense fatigue which impaired his daily activities. Laboratory tests prior to treatment revealed the following: ALT: 67 U/l (N: 5- 40), AST: 38 U/l (N: 5- 40), ALP: 683 U/l (N: 50-200), Direct Bil: 0.6 mg/dl, Total Bil: 1.4 mg/dl, Hb: 16.2 g/dl, and CA19-9: 86 U/ml (N: 0-40 U/ml). In the traditional medicine clinic, the patient was treated with health and nutrition improvement measures. The medications prescribed included a combination of herbal plants based on the patient’s disease. After 45days of treatment, the patient’s fatigue intensity, skin pruritus and feeling of depression reduced and he returned to an active life. Laboratory tests after treatment revealed: ALT: 44 U/l (N: 5-40), AST: 30 U/l (N: 5- 40), ALP: 520 U/l (N: 50-200), Direct Bil: 0.25 mg/dl, Total Bil: 1 mg/dl, and CA 19-9: 60 U/ml (N: 0-40 U/ml). Conclusion: Due to the patient’s physical and mental improvement, as well as significant improvement in symptoms, it seems that Iranian traditional medicine can successfully treat many common diseases.
similar resources
Primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disorder of the biliary system that results in progressive fibrosis and strictures of the intrahepatic and extrahepatic bile ducts. Typical radiological changes on retrograde cholangiography are shown in Figure 1. These strictures cause cholestatic liver disease that may progress to end-stage cirrhosis. The disorder has a strong ass...
full textPrimary Sclerosing Cholangitis: Introduction
The prevalence of primary sclerosing cholangitis in the United States is approximately 1–6 cases per 100,000 population. Most patients with primary sclerosing cholangitis are men (75%) with an average age of approximately 40 years at diagnosis. The overwhelming majority of patients affected with primary sclerosing cholangitis are Caucasian. The etiology is unknown but current opinion favors an ...
full textPrimary sclerosing cholangitis.
PRIMARY sclerosing cholangitis, stenosing cholangitis, fibrosing cholangitis, chronic obliterative cholangitis are all terms referring to a rare diffuse type ofchronic inflammation of the entire common bile duct and at times of the hepatic ducts and their radicles. In most instances, sclerosing cholangitis is idiopathic or primary. Bartholomew et al., in 1963 found only twenty unequivocal cases...
full textPrimary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a fibrosing disease of the intra- and extra-hepatic bile ducts, and is closely associated with inflammatory bowel disease. It is immune mediated, rather than being a classical autoimmune disease. A range of immune abnormalities have been demonstrated in PSC, in particular the findings of a range of autoantibodies, a portal tract infiltrate of functional T...
full textPrimary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is an uncommon disorder of unknown etiology, characterized by chronic inflammation and fibrosis of the intra- and extrahepatic bile ducts. PSC is commonly associated with chronic inflammatory bowel disease, especially ulcerative colitis, and often in younger men with an extensive colitis. The diagnosis is made by endoscopic retrograde cholangiography. The ch...
full textPrimary sclerosing cholangitis.
Primary sclerosing cholangitis (PSC) is a generally progressive, sometimes fatal chronic hepatobiliary disorder for which no effective medical therapy now exists. This article describes the epidemiology of this disease, along with diagnosis and treatment options. Future research directions concerning PSC also are discussed.
full textMy Resources
Journal title
volume 1 issue Issue 2-3
pages 33- 38
publication date 2017-09-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023